Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

Similar articles for PubMed (Select 22123665)

1.

Varicella vaccines.

Javed S, Javed SA, Tyring SK.

Curr Opin Infect Dis. 2012 Apr;25(2):135-40. doi: 10.1097/QCO.0b013e32834c1863. Review.

PMID:
22123665
2.

Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.

[No authors listed]

Prescrire Int. 2005 Jun;14(77):85-91.

PMID:
15977369
3.

Varicella zoster vaccines.

Creed R, Satyaprakash A, Ravanfar P.

Dermatol Ther. 2009 Mar-Apr;22(2):143-9. doi: 10.1111/j.1529-8019.2009.01226.x. Review.

PMID:
19335725
4.

Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.

Sanford M, Keating GM.

Drugs Aging. 2010 Feb 1;27(2):159-76. doi: 10.2165/10489140-000000000-00000. Review.

PMID:
20104941
5.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Hornberger J, Robertus K.

Ann Intern Med. 2006 Sep 5;145(5):317-25.

PMID:
16954357
6.

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL; Shingles Prevention Study Group.

N Engl J Med. 2005 Jun 2;352(22):2271-84.

7.

[Immunization of adults against varicella and herpes zoster].

Hanslik T, Blanchon T, Alvarez FP.

Rev Med Interne. 2007 Mar;28(3):166-72. Epub 2007 Jan 17. Review. French.

PMID:
17270316
8.
9.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
10.

Vaccination: a new option to reduce the burden of herpes zoster.

Mick G.

Expert Rev Vaccines. 2010 Mar;9(3 Suppl):31-5. doi: 10.1586/erv.10.32. Review.

PMID:
20192716
11.

Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

Betts RF.

J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7.

PMID:
18021866
12.

Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.

Levin MJ, Schmader K.

Herpes. 2007 Sep;14 Suppl 2:45-7. Review.

PMID:
17939896
13.

The varicella vaccine. Clinical trials in immunocompromised individuals.

Gershon AA, LaRussa P, Steinberg S.

Infect Dis Clin North Am. 1996 Sep;10(3):583-94. Review.

PMID:
8856353
14.

Live attenuated varicella vaccine use in immunocompromised children and adults.

Gershon AA, Steinberg SP, Gelb L.

Pediatrics. 1986 Oct;78(4 Pt 2):757-62.

PMID:
3020495
15.

Prevention of herpes zoster and its painful and debilitating complications.

Johnson R, McElhaney J, Pedalino B, Levin M.

Int J Infect Dis. 2007 Nov;11 Suppl 2:S43-8. doi: 10.1016/S1201-9712(07)60021-6. Review.

16.

Varicella zoster virus vaccines: potential complications and possible improvements.

Silver B, Zhu H.

Virol Sin. 2014 Oct;29(5):265-73. doi: 10.1007/s12250-014-3516-9. Epub 2014 Oct 24. Review.

PMID:
25358998
17.

Chickenpox party or varicella vaccine?

Hambleton S, Arvin AM.

Adv Exp Med Biol. 2005;568:11-24. Review.

PMID:
16107063
18.

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Rothberg MB, Virapongse A, Smith KJ.

Clin Infect Dis. 2007 May 15;44(10):1280-8. Epub 2007 Apr 3.

19.

Live attenuated varicella vaccine.

Arvin AM, Gershon AA.

Annu Rev Microbiol. 1996;50:59-100. Review.

PMID:
8905076
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk